Screening for clinically significant non-deletional alpha thalassaemia mutations by pyrosequencing.
Non-deletional α(+)-thalassaemia is associated with a higher degree of morbidity and mortality than deletional forms of α(+)-thalassaemia. Screening for the common deletional forms of α-thalassaemia by Gap-PCR is widely practiced; however, the detection of non-deletional α-thalassaemia mutations is...
Main Authors: | Haywood, A, Dreau, H, Timbs, A, Schuh, A, Old, J, Henderson, S |
---|---|
Formato: | Journal article |
Idioma: | English |
Publicado em: |
2010
|
Registos relacionados
-
Multiplex ligation-dependent probe amplification identification of 17 different beta-globin gene deletions (including four novel mutations) in the UK population.
Por: Gallienne, A, et al.
Publicado em: (2009) -
Non-deletional alpha thalassaemia: a review
Por: Ibrahim Kalle Kwaifa, et al.
Publicado em: (2020-06-01) -
Non-deletional alpha thalassaemia: a review of emerging therapy
Por: Khairil Wahidin, Nurfhaezah, et al.
Publicado em: (2021) -
Screening of concurrent alpha-Thalassaemia 1 in beta-Thalassaemia carriers
Por: Chong, Y.M., et al.
Publicado em: (2006) -
Screening of Alpha-Thalassaemia 1 in Beta-Thalassaemia Carriers
Por: Chong, Yi Min
Publicado em: (2005)